A. Pawełczyk, L. Zaprutko / European Journal of Medicinal Chemistry 44 (2009) 3032–3039
3037
[Mþ], 150 (58), 136 (6), 124 (19), 112 (25), 98 (27), 84 (100), 70 (23),
Rf ¼ 0.66 (chloroform:ethanol 10:1). MS, m/z (%): 168 (16) [Mþ], 153
55 (46), 41 (51). IR (cmꢀ1): 1685 (
n
C]O). 1H NMR (CDCl3):
d
¼ 1.12
(1), 139 (10), 126 (1), 113 (100), 99 (23), 85 (7), 69 (20), 57 (47). IR
(t, J ¼ 7.5 Hz, 3H, CH3-50), 1.25 (d, J ¼ 6.6 Hz, 3H, CH3), 1.45–1.58 (m,
1H, CH2-40), 2.13–2.25 (m, superimposed bands: 2H (CH2-4) and 1H
(CH2-40)); 2.52–2.74 (m, 2H, CH2-3), 3.80–3.87 (m, 2H, CH2-10),
(cmꢀ1): 1660 (
n
C]O). 1H NMR (CDCl3):
d
¼ 0.90 (t, J ¼ 6.9 Hz, 3H,
CH3-50), 1.87–1.99 (m, 2H, CH2-40), 2.58–2.67 (m, 2H, CH2-4), 3.30 (s,
3H, CH3), 3.45–3.54 (m, 2H, CH2-10), 3.79–3.88 (m, 2H, CH2-5), 5.22–
5.29 (m, 1H, trans-CH]), 5.58–5.64 (m, 1H, trans-CH]). 13C NMR
4.04–4.16 (m, 1H, CH-5). 13C NMR (CDCl3):
d
¼ 12.52 (CH3), 13.77
(CH3-50), 19.64 (C-40), 22.02 (C-3), 31.39 (C-4), 38.36 (C-5), 67.97
(CDCl3):
d
¼ 13.98 (CH3-50), 22.47 (C-40), 43.20 (CH3), 50.54 (C-5),
(C-10), 74.07/84.89 (C^C), 170.10 (C]O). C10H15NO (165.1).
58.97 (C-4), 65.18 (C-10), 121.68/136.57 (trans-CH]CH), 167.64
20
20
[
a]
¼ w0ꢁ.
(C]O). C9H16N2O (168.1). [
a]
¼ w0ꢁ.
D
D
3.2.1.1.4. 4-Methyl-3-(2-trans-pentenyl)-2-oxazolidinone (20). To
3.2.1.1.8. 1-Methyl-2-(2-cis-pentenyl)-3-pyrazolidinone (24). To
the mixture of 0.16 g of TBAB, 2.76 g of potassium carbonate and
1.12 g of potassium hydroxide, 0.50 g of 10 and subsequently 1.12 g
of 1-bromo-2-cis-pentene were added. Reagents were irradiated in
the microwave reactor. The crude product was purified by a column
chromatography, using a mixture of chloroform and ethanol 10:1 as
an eluent, yielding 0.25 g (30%) of 24 as yellow oil (b.p. 219–225 ꢁC).
Rf ¼ 0.70 (chloroform:ethanol 10:1). MS, m/z (%): 168 (10) [Mþ], 153
(5), 139 (13), 126 (2), 113 (70), 99 (100), 85 (9), 69 (22), 57 (41). IR
the mixture of 0.16 g of TBAB, 2.76 g of potassium carbonate and
1.12 g of potassium hydroxide 0.50 g of 9 and subsequently 1.12 g of
1-bromo-2-trans-pentene were added. Reagents were irradiated in
the microwave reactor. The crude product was purified by a column
chromatography, using a mixture of hexane and ethyl acetate 1:1 as
an eluent, yielding 0.73 g (85%) of 20 as colorless oil (b.p. 294–
299 ꢁC). Rf ¼ 0.67 (hexane:ethyl acetate 1:1). MS, m/z (%): 169 (26)
[Mþ], 154 (11), 140 (84), 127 (2), 114 (78), 100 (6), 86 (17), 70 (23), 69
(36), 56 (36), 41 (100). IR (cmꢀ1): 1685 (
d
n
C]O). 1H NMR (CDCl3):
(cmꢀ1): 1670 (
n
C]O). 1H NMR (CDCl3):
d
¼ 1.10 (t, J ¼ 6.9 Hz, 3H,
¼ 0.99 (t, J ¼ 7.5 Hz, 3H, CH3-50), 1.25 (d, J ¼ 6.0 Hz, 3H, CH3), 2.01–
CH3-50), 2.17–2.23 (m, 2H, CH2-40), 2.62–2.68 (m, 2H, CH2-4), 3.32
(s, 3H, CH3), 3.40–3.51 (m, 2H, CH2-10), 3.81–3.92 (m, 2H, CH2-5),
5.25–5.31 (m,1H, cis-CH]), 5.59–5.65 (m,1H, trans-CH]). 13C NMR
2.16 (m, 2H, CH2-40), 3.52–3.60 (m, 1H, CH2-10), 3.79–3.93 (m,
superimposed bands: 1H (CH2-10) and 2H (CH2-5)), 4.40 (t,
J ¼ 7.7 Hz, 1H, CH-4), 5.32–5.42 (m, 1H, trans-CH]), 5.58–5.79 (m,
(CDCl3):
d
¼ 13.86 (CH3-50), 22.52 (C-40), 43.45 (CH3), 50.87 (C-5),
1H, trans-CH]). 13C NMR (CDCl3):
d
¼ 12.81 (CH3), 17.46 (CH3-50),
59.03 (C-4), 65.23 (C-10),121.88/136.67 (cis-CH]CH),167.87 (C]O).
20
24.62 (C-40), 43.15 (C-4), 49.89 (C-10), 68.34 (C-5), 121.94/136.03
C9H16N2O (168.1). [
a]
¼ w0ꢁ.
D
20
(trans-CH]CH), 157.16 (C]O). C9H15NO2 (169.0). [
a]
¼ w0ꢁ.
3.2.1.1.9. 1-Methyl-2-(2-pentynyl)-3-pyrazolidinone (25). To the
mixture of 0.16 g of TBAB, 2.76 g of potassium carbonate and 1.12 g
of potassium hydroxide 0.50 g of 10 and subsequently 1.10 g of 1-
bromo-2-pentyne were added. Reagents were irradiated in the
microwave reactor. The crude product was purified by a column
chromatography, using a mixture of chloroform and ethanol 10:1 as
an eluent, yielding 0.20 g (25%) of 25 as yellow oil (b.p. 234–
240 ꢁC). Rf ¼ 0.63 (chloroform:ethanol 10:1). MS, m/z (%): 166 (2)
[Mþ], 151(3), 137 (6), 125 (3), 113 (100), 99 (11), 81 (41), 67 (25). IR
D
3.2.1.1.5. 4-Methyl-3-(2-cis-pentenyl)-2-oxazolidinone (21). To
the mixture of 0.16 g of TBAB, 2.76 g of potassium carbonate and
1.12 g of potassium hydroxide 0.50 g of 9 and subsequently 1.12 g of
1-bromo-2-cis-pentene were added. Reagents were irradiated in
the microwave reactor. The crude product was purified by a column
chromatography, using a mixture of hexane and ethyl acetate 1:1 as
an eluent, yielding 0.61 g (73%) of 21 as colorless oil (b.p. 297–
302 ꢁC). Rf ¼ 0.76 (hexane:ethyl acetate 1:1). MS, m/z (%): 169 (28)
[Mþ], 154 (14), 140 (85), 127 (3), 114 (100), 100 (9), 86 (25), 70 (41),
(cmꢀ1): 1680 (
n
C]O). 1H NMR (CDCl3): 0.92 (t, J ¼ 7.0 Hz, 3H, CH3-
69 (70), 56 (60). IR (cmꢀ1): 1685 (
n
C]O). 1H NMR (CDCl3):
d
¼ 1.00
50), 1.85–1.97 (m, 2H, CH2-40), 2.54–2.65 (m, 2H, CH2-4), 3.33 (s, 3H,
CH3), 3.81–3.92 (m, superimposed bands: 2H (CH2-10) and 2H (CH2-
(t, J ¼ 7.5 Hz, 3H, CH3-50), 1.26 (d, J ¼ 6.0 Hz, 3H, CH3), 2.01–2.19 (m,
2H, CH2-40), 3.72–3.90 (m, superimposed bands: 1H (CH2-10) and
2H (CH2-5)), 4.01–4.12 (m, 1H, CH2-10), 4.39 (t, J ¼ 7.5 Hz, 1H, CH-4),
5.28–5.42 (m, 1H, cis-CH]), 5.57–5.78 (m, 1H, cis-CH]). 13C NMR
5)). 13C NMR (CDCl3):
50.91 (C-5), 60.23 (C-4), 65.76 (C-10), 75.62/77.31 (CH^CH), 168.03
(C]O). C9H14N2O (166.1). [
d
¼ 13.89 (CH3-50), 22.63 (C-40), 43.53 (CH3),
20
a]
¼ w0ꢁ.
D
(CDCl3):
d
¼ 13.82 (CH3), 17.83 (CH3-50), 24.86 (C-40), 43.45 (C-4),
50.27 (C-10), 68.65 (C-5),122.31/135.85 (cis-CH]CH),157.74 (C]O).
3.2.2. Synthesis of pyrazolone heteroanalogues of jasmone
Compounds 11–13, necessary to obtain pyrazolone hetero-
analogues, were prepared according to the method described
earlier [9].
20
C9H15NO2 (169.1). [
a]
¼ w0ꢁ.
D
3.2.1.1.6. 4-Methyl-3-(2-pentynyl)-2-oxazolidinone (22). To the
mixture of 0.16 g of TBAB, 2.76 g of potassium carbonate and 1.12 g
of potassium hydroxide, 0.50 g of 9 and subsequently 1.10 g of 1-
bromo-2-pentyne were added. Reagents were irradiated in the
microwave reactor. The crude product was purified by a column
chromatography, using a mixture of hexane and ethyl acetate 1:1 as
an eluent, yielding 0.67 g (80%) of 22 as colorless oil (b.p. 310–
315 ꢁC). Rf ¼ 0.62 (hexane:ethyl acetate 1:1). MS, m/z (%):167 (20)
[Mþ],152 (9), 138 (1), 126 (27), 114 (11), 100 (8), 86 (100), 70 (21), 67
3.2.2.1. General procedure for cyclocondensation to pyrazolone
cycles. To the solution of 5 mmol of ethyl 2-alkyl acetylacetate (11,
12 or 13) in 20 ml of anhydrous ethanol, 10 mmol of 99% hydrazine
hydrate was added. Reagents, in a calibrated flask with condenser,
were irradiated for 10 min with 160 W power of microwaves. The
obtained solution was concentrated in vacuo, yielding crude
product, which was purified by crystallization from benzene.
3.2.2.1.1. 5-Methyl-4-(2-trans-pentenyl)-1,2-dihydro-3-pyrazolone
(26). To the solution of 0.99 g of 11 in 20 ml of anhydrous ethanol,
0.50 g of 99% hydrazine hydrate was added. Reagents were irradiated
in the microwave reactor. The crude product was isolated and
crystallized from benzene yielding 0.50þg (60%) of white crystals
(m.p.178–182 ꢁC). MS, m/z (%): 166 (9) [M ],151 (3),137 (23),124 (2),
(45), 56 (16), 42 (84). IR (cmꢀ1): 1685 ( C]O).1H NMR (CDCl3):
n
d
¼ 1.12 (t, J ¼ 7.5 Hz, 3H, CH3-50), 1.28 (d, J ¼ 6.6 Hz, 3H, CH3), 2.14–
2.24 (m, 2H, CH2-40), 3.73–3.80 (m, 2H, CH2-5), 3.84–3.94 (m, 1H,
CH2-10), 4.19–4.28 (m, 1H, CH2-10), 4.45 (t, J ¼ 7.5 Hz, 1H, CH-4). 13C
NMR (CDCl3):
d
¼ 12.60 (CH3), 13.79 (CH3-50), 21.38 (C-40), 43.24
(C-4), 62.09 (C-10), 73.37 (C-5), 75.67/77.42 (C^C), 163.82 (C]O).
20
C9H13NO2 (167.1). [
a]
¼ w0ꢁ.
D
3.2.1.1.7. 1-Methyl-2-(2-trans-pentenyl)-3-pyrazolidinone (23). To
the mixture of 0.16 g of TBAB, 2.76 g of potassium carbonate and
1.12 g of potassium hydroxide, 0.50 g of 10 and subsequently 1.12 g of
1-bromo-2-trans-pentene were added. Reagents were irradiated in
the microwave reactor. The crude product was purified by a column
chromatography, using a mixture of chloroform and ethanol 10:1 as
an eluent, yielding 0.28 g (33%) of 23 as yellow oil (b.p. 228–234 ꢁC).
111 (100), 97 (4), 82 (5), 69 (13), 53 (7), 41 (16). IR (cmꢀ1): 1600 (
n
C]O). 1H NMR (DMSO):
d
¼ 0.85 (t, J ¼ 6.8 Hz, 3H, CH3-50), 2.02 (s,
3H, CH3), 2.01–2.09 (m, 2H, CH2-40), 3.25–3.30 (m, 2H, CH2-10), 5.30–
5.38 (m, 2H, trans-CH]CH), 9.21 (br s, 1H, NH), 10.99 (br s, 1H, NH).
13C NMR (DMSO):
d
¼ 9.91 (CH3), 14.04 (CH3-50), 22.02 (C-40), 24.80
(C-20), 98.73 (C-4), 127.84/130.71 (trans-CH]CH), 136.52 (C-5),
20
159.15 (C]O). C9H14N2O (166.1). [
a]
¼ w0ꢁ.
D